VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,459 | +5.9% | 42 | 0.0% | 0.00% | – |
| Q2 2023 | $1,378 | -2.1% | 42 | 0.0% | 0.00% | – |
| Q1 2023 | $1,407 | +2.2% | 42 | 0.0% | 0.00% | – |
| Q4 2022 | $1,377 | -31.2% | 42 | -32.3% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 62 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 62 | -38.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 686,370 | $23,837,630 | 31.65% |
| venBio Partners LLC | 758,800 | $26,353,124 | 7.47% |
| ACUTA CAPITAL PARTNERS, LLC | 205,377 | $7,132,743 | 4.78% |
| TCG Crossover Management, LLC | 815,724 | $28,330,095 | 4.17% |
| Integral Health Asset Management, LLC | 430,000 | $14,933,900 | 2.07% |
| Vivo Capital, LLC | 422,075 | $14,658,665 | 1.61% |
| Boxer Capital, LLC | 850,000 | $29,520,500 | 1.57% |
| Redmile Group, LLC | 929,900 | $32,295,427 | 1.54% |
| Logos Global Management LP | 225,000 | $7,814,250 | 1.04% |
| Birchview Capital, LP | 26,400 | $916,872 | 0.78% |